Report of Foreign Issuer (6-k)
August 20 2018 - 7:26AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2018
--------------
Commission File Number: 001-32371
----------
SINOVAC
BIOTECH LTD.
No. 15 Zhi Tong Road
Zhongguancun Science and Technology Park
Changping District
Beijing 102200, People’s Republic
of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F
x
Form
40-F
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1):________________
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7):________________
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
SINOVAC BIOTECH LTD.
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Nan Wang
|
|
|
Name:
|
Nan Wang
|
|
|
Title:
|
Chief Financial Officer
|
|
Date: August 20, 2018
Exhibit Index
|
Exhibit 99.1
|
Press
Release
|
Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart
From Apr 2024 to May 2024
Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart
From May 2023 to May 2024